LIVE

€616.43 ▼−2.96%

/Ruby & Sapphire/Weezing

Variants

STANDARD · Conviction 5/10

Weezing

Ruby & Sapphire · #24 · Rare

Graded

PSA 9€45.37

PSA 10€54.22

Composite

5.3

Not yet verifiedEU 58% below US

Buy range€1.24 – €1.62Suspect — verify variant

All prices and projections are for Near Mint English-language cards. Other conditions and languages may vary significantly.

Price history

Ungraded NM PSA 9 PSA 10

Investment thesis

Sub-score breakdown · ROI projections

5.3

SCORE / 10

Liquidity

9.5

Scarcity

10.0

Era potential

8.9

Friction

3.8

Hold-Raw · 5Y Outlook▲ PRIMARY

+•••%

Available with Pro

Grade or sell · per-card

Free account

See if grading this card pays.

How is this scored?

The composite score (0–10) blends signals across trust, set tier, era, liquidity, and price. The four sub-scores shown above (Liquidity, Scarcity, Era CAGR, Friction) describe each card across complementary axes; they share inputs with the composite but use different formulas. The Friction sub-score (added 2026-05-11) combines liquidity, price-spread stability, era maturity, and affordability minus a flat marketplace-fee proxy. The era-benchmark ROI numbers project returns based on the card's release era — they're not card-specific predictions. Limitations: the score is a relative ranking heuristic, not a forecast. Prices are snapshots and can drift between refreshes — always verify externally before buying.

Pop report

PSA 10 gem rate 11.76%Total population

PSA 10

PSA 9

126

PSA 8

Total graded

374

Gem rate 11.76%. Consistent with modern era gem rates; expect supply to grow as more are graded.

OVERVIEW

Investment summary

Ruby & Sapphire's Weezing (#24) currently trades at €3.21 in the raw market. Its 30-day price movement has declined (-33.3%). By market value it ranks #81 of 109 in Ruby & Sapphire — the 25th percentile of the set. With recent sales tracked over the trailing 180 days, liquidity is rated medium. Read together, a lower-tier ranking in Ruby & Sapphire alongside softening 30-day momentum frames where Weezing sits in the set's pricing structure — context worth weighing against the set's stronger names before timing an entry. Market data is informational only and does not constitute investment advice.